Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
Funding Boost for PulseMedica’s Eye Floater Technology
PulseMedica has successfully raised a total of $12 million in their recent pre-Series A financing round, marking a significant milestone in their pursuit of innovative eye floater diagnostic and treatment technologies. Accelerating Clinical Validation and Expansion Efforts This funding round…
FDA Clears Enhanced SPECTRALIS® OCTA Module by Heidelberg
Heidelberg Engineering announced the FDA clearance of its upgraded SPECTRALIS® OCTA Module featuring SHIFT technology. This advancement promises to significantly reduce acquisition time by 50%, marking a pivotal development in clinical efficiency and diagnostic precision within ophthalmology. Enhancing Clinical Utility…
Sydnexis Appoints Perry J. Sternberg as CEO
Sydnexis, Inc., a pioneering biopharmaceutical company dedicated to addressing pediatric myopia progression, has appointed Perry J. Sternberg as its Chief Executive Officer and as a member of its Board of Directors. Sternberg, a seasoned pharmaceutical and biotech executive with over…
VSY Biotechnology: Who Will Shine at the OSA 2024?
VSY Biotechnology GmbH, a leading company with innovative ophthalmic solutions, is now accepting submissions for Ophthalmology Star Awards (OSA) 2024 from eye care professionals worldwide. The awards aim to celebrate and promote novel research and advancements in ophthalmology, with winners…
NVISION Eye Centers Partners with Parkhurst NuVision
NVISION Eye Centers, a prominent provider of eye care services nationwide, announced a strategic collaboration with Parkhurst NuVision of San Antonio, Texas, through its subsidiary NVision Clinical Research, LLC. This partnership aims to advance clinical trials in ophthalmology drug development,…
4DMT Receives FDA Clearance of IND for GA Treatment
4D Molecular Therapeutics (4DMT) announced the FDA clearance of its investigational new drug application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine intended for treating geographic atrophy (GA) in patients. Phase 1 GAZE Clinical Trial Details The phase 1…
Ikerian Receives EU-MDR Certificate for Four Medical Devices
Ikerian has received European Union Medical Device Regulation (EU-MDR) certificate for its RetinAI Discovery digital data platform and AI-based models. These products have been classified as Class IIa medical devices, affirming their adherence to stringent regulatory standards for healthcare technology.…
VSY Biotechnology’s SVT Granted Patent in China
VSY Biotechnology registered a patent with the People’s Republic of China for the ‘Sinusoidal Vision Technology’ used in AcrivaUD Trinova Pro C Pupil Adaptive®, the world’s first and only sinusoidal trifocal intraocular lens. As a result of evaluations, office actions,…
Use of Telemedicine in Ophthalmology
The medical industry is undergoing radical change as we enter the digital age. One such change is the advent of telemedicine – a powerful tool enabling healthcare providers to connect with patients remotely. Ophthalmology, the branch of medicine dedicated to…
DORC Receives FDA Clearance for Eva Nexus System
DORC International has announced 510(k) market clearance and the launch of the Eva Nexus. According to DORC, the Eva Nexus features multiple innovations to improve performance, efficiency, and stability for retina surgeons, including Smart IOP for anterior and posterior chamber stability; DORC’s trocar cannula system with HI-FLOW infusion…